Title: Research Communications of the 24th ECVIM-CA Congress Document date: 2015_1_10
ID: r59usk02_264
Snippet: No conflicts of interest reported. Subcutaneous mast cell tumours (SQMCT) in dogs are relatively uncommon compared to their cutaneous counterparts. The veterinary literature describes these tumours as a specific pathological entity with, in general, a low probability of aggressive progression. Surgery is considered the main treatment modality, while medical treatment has not been described. The purpose of this study was to determine Progression F.....
Document: No conflicts of interest reported. Subcutaneous mast cell tumours (SQMCT) in dogs are relatively uncommon compared to their cutaneous counterparts. The veterinary literature describes these tumours as a specific pathological entity with, in general, a low probability of aggressive progression. Surgery is considered the main treatment modality, while medical treatment has not been described. The purpose of this study was to determine Progression Free Survival (PFS) for a chemo na€ ıve cohort of dogs presented with non-resectable and/ or metastasized SQMCT, which all underwent masitinib-based therapy.
Search related documents:
Co phrase search for related documents- medical treatment and treatment modality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- pathological entity and specific pathological entity: 1
- pathological entity and study purpose: 1
- Progression PFS Free Survival determine and study purpose: 1
- study purpose and treatment modality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- study purpose and veterinary literature: 1
Co phrase search for related documents, hyperlinks ordered by date